Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bushra Y. Abo Halawa"'
Autor:
Farah M. Shurrab, Duaa W. Al-Sadeq, Haissam Abou-Saleh, Nader Al-Dewik, Amira E. Elsharafi, Fatima M. Hamaydeh, Bushra Y. Abo Halawa, Tala M. Jamaleddin, Huda M. Abdul Hameed, Parveen B. Nizamuddin, Fathima Humaira Amanullah, Hanin I. Daas, Laith J. Abu-Raddad, Gheyath K. Nasrallah
Publikováno v:
Vaccines, Vol 10, Iss 2, p 191 (2022)
The currently authorized mRNA COVID-19 vaccines, Pfizer-BNT162b2 and Moderna-mRNA-1273, offer great promise for reducing the spread of the COVID-19 by generating protective immunity against SARS-CoV-2. Recently, it was shown that the magnitude of the
Externí odkaz:
https://doaj.org/article/dd53fde9049c4b0fb45831c6d3e21bd8
Autor:
Salma Younes, Eleonora Nicolai, Duaa W. Al-Sadeq, Nadin Younes, Nader Al-Dewik, Haissam Abou-Saleh, Bushra Y. Abo-Halawa, Ali Hussein Eid, Massimo Pieri, Na Liu, Hanin I. Daas, Hadi M. Yassine, Parveen B. Nizamuddin, Laith J. Abu-Raddad, Gheyath K. Nasrallah
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 11, Pp 1729-1735 (2023)
Background: Evidence on the effectiveness of vaccination-induced immunity compared to SARS-CoV-2 natural immunity is warranted to inform vaccination recommendations. Aim: In this study, we aimed to conduct a comparative assessment of antibody respons
Externí odkaz:
https://doaj.org/article/8d1b39b4397549b2b285b91f76bb2099
Autor:
Haissam Abou-Saleh, Bushra Y Abo-Halawa, Salma Younes, Nadin Younes, Duaa W Al-Sadeq, Farah M Shurrab, Na Liu, Hamda Qotba, Nader Al-Dewik, Ahmed Ismail, Hadi M Yassine, Laith J Abu-Raddad, Gheyath K Nasrallah
Background Waning protection against emerging SARS-CoV-2 variants by pre-existing antibodies elicited because of current vaccination or natural infection is a global concern. Whether this is due to the waning of immunity to SARS-COV-2 remains unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3907f419eade04fa7d768679821854f
Autor:
Nadin Younes, Duaa W. Al-Sadeq, Farah M. Shurrab, Hadeel T. Zedan, Haissam Abou-Saleh, Bushra Y. Abo-Halawa, Fatima M. AlHamaydeh, Amira E. Elsharafi, Hanin I. Daas, Swapna Thomas, Sahar Aboalmaaly, Afra Al Farsi, Reeham Al-Buainain, Samar Ataelmannan, Jiji Paul, Amana Salih Al Saadi, Hadi M. Yassine, Amin F. Majdalawieh, Ahmed Ismail, Laith J. Abu-Raddad, Gheyath K. Nasrallah
Publikováno v:
Vaccines; Volume 10; Issue 8; Pages: 1318
BackgroundLimited commercial LFA assays are available to provide a reliable quantitative measurement of the total binding antibody units (BAU/mL) against the receptor-binding domain of the SARS-CoV-2 spike protein (S-RBD).AimTo evaluate the performan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ac20ed0a15fede93a79e432b6b911f
Autor:
Haissam Abou-Saleh, Bushra Y. Abo-Halawa, Salma Younes, Nadin Younes, Duaa W. Al-Sadeq, Farah M. Shurrab, Na Liu, Hamda Qotba, Nader Al-Dewik, Ahmad H. Ismail, Hadi M. Yassine, Laith J. Abu-Raddad, Gheyath K. Nasrallah
1.AbstractBackgroundWaning of protection against emerging SARS-CoV-2 variants by pre-existing antibodies elicited due to current vaccination or natural infection is a global concern. Whether this is due to waning of immunity to SARS-COV-2 remains unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d33bebfa1216b3f907ed1a1b1b2a1e6
https://doi.org/10.1101/2022.05.08.22274817
https://doi.org/10.1101/2022.05.08.22274817